However, in the AAA + BE group, it was found that the decline in medial α-SMA staining-positive area was significantly attenuated by baicalein treatment (15.57 ± 0.70%, p < 0.01), suggesting that the baicalein treatment mitigated the quantitative reduction in VSMC content during aneurysm formation. Here, ACTA1 is linked to triple-A syndrome.